FutuRx
Investor Israel Est. 2014
Team
5
Confidence
56/100
News
7
articles
About
FutuRx was founded by Johnson & Johnson Innovation – JJDC, Takeda Pharmaceutical Company, through its venture group Takeda Ventures Inc.-TVI and OrbiMed Israel Partners together with the Israeli Innovation Authority of the Ministry of Economy and later joined by Leaps by Bayer, the impact investments unit of Bayer AG. The FutuRx incubator is dedicated to the inception of early-stage biopharma ventures based on cutting edge science and supporting them in successful drug development FutuRx strives to be a catalyst for drug development by bridging the gap between concept and proof of concept through its dedicated system and structure. FutuRx's management, together with its founders, will establish and fully support companies via its in-house laboratory and management facility. FutuRx provides a unique model for supporting early-stage innovation, by combining expertise of FutuRx management team, and global capabilities of the founders, teamed with the Technological Incubators Program at the Israeli Innovation Authority. Companies established by FutuRx benefit from professional assistance by industry leading experts. These global capabilities facilitate the development of innovative technologies, on the way to safely turning them into cutting-edge products for the benefit of patients and healthcare providers.
Classification
Tags
drug-discoverybiopharmaceuticaltherapeuticsbiotechnologypharmaceuticals
News (7)
Dec 18, 2020 · www.businesswire.com
Atomwise and FutuRx Launch A2i Therapeutics - A New Immuno-Oncology Company Funded By Leading Biopharma VCs and the Israeli Innovation Authority
Jul 28, 2020 · www.marketwatch.com
https://www.marketwatch.com/press-release/biotech-incubator-futurx-announces-new-investor-leaps-by-bayer-2020-07-28
Apr 8, 2019 · en.globes.co.il
growth-positive
RM Global raises $64m for FutuRx investments
Investment
May 19, 2017 · www.globes.co.il
growth-positive
RM Global to invest $30m in FutuRx biotech startups
Investment
Jan 19, 2015 · www.timesofisrael.com
growth-positive
J&J, Takeda team up to open Israeli biotech incubator
PartnersInvestment
Jan 14, 2015 · www.globes.co.il
growth-positive
FutuRx biotech incubator selects first two projects
Investment
Oct 2, 2014 · www.israel21c.org
growth-positive
Israel takes a risk on tomorrow's epic drugs
InvestmentPartners
Locations
Park Hamada Ilan Ramon St 2, Ness Ziona, Israel
Links
Website
LinkedIn
Admin
Last Update
Sep 16, 2024
Verified by
Jenny Sotnik-Talisman
Missing
product stage, sector, number of employees, business model, tag line, video or image, markets, not claimed
Team (5)
Lianna Patt
CEO
Modi Teicher
CBO
Aric Orbach
CTO
Inbal Michailovici
Director of Business Development
Shahar Nir
HR Manager
Internal
Created
2016-01-04T00:00:00.000Z
Last editor
Ortal Wein (ortalw@sncentral.org)
Status
Active
Recent activity
Maor Perlov · Manual · 2023-07-18 14:06:54.000000
Ortal Wein · Manual · 2022-10-25 09:19:07.000000
Ortal Wein · Manual · 2022-10-25 09:15:49.000000
Matan Eblagon · Manual · 2024-09-16 21:01:11.000000
Matan Eblagon · Manual · 2024-09-16 21:05:47.000000
Matan Eblagon · Manual · 2024-09-16 21:01:17.000000
Matan Eblagon · Manual · 2024-09-16 21:17:23.000000
Ortal Wein · Manual · 2022-10-25 09:18:57.000000
Matan Eblagon · Automatic · 2024-09-16 21:01:19.000000
Ortal Wein · Manual · 2022-10-25 09:23:19.000000